Position in FBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,041
+$2,906 QoQ
Shares Held
994
+6112.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 55 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. FBIO ranks #349 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in FBIO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,041 | 994 | Shares | Defined | 2026-08-14 | |
| 2023-06-30 | $135 | 247 | Shares | Sole | 2026-03-27 | |
| 2022-03-31 | $16,201 | 11,913 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $225,862 | 90,345 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $110,645 | 34,362 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $32,358 | 9,064 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $197,266 | 55,883 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $68,402 | 21,578 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $116,000 | 28,713 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $85,127 | 31,764 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||